Pradua prediction score
Jump to navigation
Jump to search
Indications
- assessment of risk for inpatient venous thromboembolism
Clinical significance
Procedure
Table
| risk factor | points |
|---|---|
| active cancer | 3 |
| previous VTE* | 3 |
| reduced mobility for >= 3 days | 3 |
| hypercoagulability (thrombophilia) | 3 |
| recent surgery or trauma (< 1 month) | 2 |
| age >= 70 years | 1 |
| heart failure &/or respiratory failure | 1 |
| acute MI* or stroke | 1 |
| acute infection or rheumatologic disorder | 1 |
| obesity (BMI >- 30) | 1 |
| hormonal treatment (current) | 1 |
* MI: myocardial infarction, VTE: venous thromboembolism
- antithrombin deficiency
- protein C deficiency
- protein S deficiency
- factor V Leiden
- G20210A prothrombin mutation
- antiphospholipid syndrome
Interpretation
Table
| score | risk for VTE | pharmcacologic prophylaxis |
|---|---|---|
| <4 | low *<0.3%) | no |
| >=4 | high (11%) | yes if no absolute contraindications |
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 19 American College of Physicians, Philadelphia 2022
- ↑ Barbar S, Noventa F, Rossetto V et al A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010 Nov;8(11):2450-7. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20738765